Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in...
Subanesthetic doses of ketamine, an N-methyl-D-aspartic acid (NMDA) antagonist, have a rapid antidepressant effect which lasts for up to 2 weeks. However, the neurobiological mechanism regarding this...